Cochrane Review: Point of Care CRP testing can safely reduce antibiotic prescribing in primary care
Antibiotic resistance has become a major public health problem, with some infections no longer treatable using currently available drugs.
The authors concluded that point of care CRP testing reduces antibiotic prescribing for patients with ARIs in primary care with no negative effects on the outcomes of patient satisfaction and re-consultation.
Check out how the fully automated Alere Afinion™ CRP test can help guide treatment decisions with excellent precision and user friendliness in 4 minutes.
Read our case study on the use of CRP testing
Read the full Cochrane Review
The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Alere or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Alere or TestTargetTreat.com. Neither Alere nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.